Cambridge Investment Research Advisors, Inc. Roivant Sciences Ltd. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 46,027 shares of ROIV stock, worth $522,406. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,027
Previous 47,768
3.64%
Holding current value
$522,406
Previous $565,000
17.88%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
336Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$747 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$702 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$522 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$463 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$408 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.99B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...